Implications of Changes in US Food and Drug Administration Prescribing Information Regarding the Safety and Use of Asthma Biologics during Pregnancy

被引：8
|
作者：
Schatz, Michael [1 ]
Krishnan, Jerry A. [2 ]
Chambers, Christina [3 ]
机构：
[1] Kaiser Permanente Med Ctr, 7060 Clairemont Mesa Blvd, San Diego, CA 92111 USA
[2] Univ Illinois, Chicago, IL USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
来源：
ANNALS OF THE AMERICAN THORACIC SOCIETY | 2018年 / 15卷 / 10期
关键词：
asthma; pregnancy; FDA; prescribing information; biologics; CONGENITAL-MALFORMATIONS; 1ST TRIMESTER; INHALED CORTICOSTEROIDS; MATERNAL ASTHMA; MEDICATION USE; RISK; WOMEN; EXACERBATIONS; ASSOCIATION; SEVERITY;
D O I：
10.1513/AnnalsATS.201806-400PP
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1131 / 1136
页数：6
相关论文
共 26 条
  • [1] Trends in Incident Varenicline Prescribing Among Veterans Following the US Food and Drug Administration Drug Safety Warnings
    Gerlach, Lauren B.
    Van, Tony
    Kim, Hyungjin Myra
    Chang, Ming-Un Myron
    Bohnert, Kipling M.
    Zivin, Kara
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2022, 83 (01)
  • [2] New US Food and Drug Administration labeling on Cytotec (Misoprostol) use and pregnancy
    不详
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2003, 82 (01) : 137 - 138
  • [3] Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends
    Tran, Phuong T.
    Antonelli, Patrick J.
    Hincapie-Castillo, Juan M.
    Winterstein, Almut G.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (06) : 808 - 816
  • [4] Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications
    Desai, Ravi J.
    Good, Meghan M.
    San-Juan-Rodriguez, Alvaro
    Henriksen, Andrew
    Cunningham, Francesca
    Hernandez, Inmaculada
    Good, Chester B.
    [J]. JAMA NETWORK OPEN, 2019, 2 (09)
  • [5] Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma
    Matsushita, Tomomi
    Sekizawa, Akihiko
    Jacobs, Lisa K.
    [J]. JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2020, 27 (01) : 178 - +
  • [6] Changes in Myomectomy Practice After the US Food and Drug Administration Safety Communication on Power Morcellation
    Stentz, Natalie C.
    Cooney, Laura G.
    Sammel, Mary
    Shah, Divya K.
    [J]. OBSTETRICS AND GYNECOLOGY, 2017, 129 (06): : 1007 - 1013
  • [7] Impact of the US Food and Drug Administration warning regarding increased risk of aortic aneurysms or aortic dissections on fluoroquinolone prescribing trends
    Rizk, John G.
    Slejko, Julia F.
    Heil, Emily L.
    Seo, Dominique
    Qato, Danya M.
    [J]. BMJ OPEN QUALITY, 2024, 13 (03) : 1 - 10
  • [8] A retrospective examination of the US Food and Drug Administration's clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring
    Fleisher, Brett
    Ait-Oudhia, Sihem
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 113 - 121
  • [9] Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program
    Feit, Noah Z.
    Goldman, Debra A.
    Smith, Evan
    Deighan, Jenny
    Iasonos, Alexia
    Zivanovic, Oliver
    Hyman, David M.
    [J]. JAMA ONCOLOGY, 2019, 5 (04) : 570 - 572
  • [10] Developing Safe and Effective Drugs for Viral Infections during Pregnancy: The US Food and Drug Administration Perspective
    Belew, Y.
    [J]. BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 723 - 723
123